‘Faster, Better, More Efficient’ – Why Bayer Is Investing In ‘Precision Health’

Bayer's head of R&D and chief scientific officer David Evendon-Challis talked to Medtech Insight about the company's prescision health business, including a holistic and personalized approach to digital self-care.